Heterozygous deficiency of Csnk1a1 (Csnk1a1+/−) in mice leads to hematopoietic stem cell (HSC) expansion and increased competitiveness [102], indicating that CK1α plays a critical role in the pathogenesis of MDS (Figure 4A). Here, CSNK1A1 is linked to myelodysplastic syndrome.